Longitudinal analysis reveals trends in reimbursed and non-reimbursed ADHD medication dispensing, suggesting guideline adjustments.
Differentiating between reimbursed and non-reimbursed dispensing is crucial to accurately describe the increasing use of this group of ADHD medication. More granular data is needed to assess whether changes to prescribing practices are necessary and to inform future development of guidelines.
No takes yet. Share an insight, caveat, or question.
Wichelen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: